RANKL is downregulated in bone cells by physical activity (treadmill and vibration stimulation training) in rat with glucocorticoid-induced osteoporosis

Histology and Histopathology

Volumn 28, Issue 9, 2013, Pages 1185-1196

  Pichler, Karin ^a   Loreto, Carla ^b   Leonardi, Rosalia ^b   Reuber, Tobias ^c   Weinberg, Annelie Martina ^a   Musumeci, Giuseppe ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Bone; Glucocorticoids; OPG; Osteoporosis; RANKL

Indexed keywords

ANIMALIA; RATTUS;

GLUCOCORTICOID; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TNFRSF11B PROTEIN, RAT;

ANIMAL; ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; BODY WEIGHT; BONE DENSITY; CHEMICALLY INDUCED DISORDER; DISEASE COURSE; DOWN REGULATION; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; OSTEOPOROSIS; RAT; VIBRATION; WISTAR RAT;

ANIMALS; BODY COMPOSITION; BODY WEIGHT; BONE DENSITY; DISEASE PROGRESSION; DOWN-REGULATION; GLUCOCORTICOIDS; IMMUNOHISTOCHEMISTRY; MALE; OSTEOPOROSIS; OSTEOPROTEGERIN; PHYSICAL CONDITIONING, ANIMAL; RANK LIGAND; RATS; RATS, WISTAR; VIBRATION;

EID: 84881145651     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Adachi J.D., Ioannidis G., Pickard L., Berger C., Prior J.C., Joseph L., Hanley D.A., Olszynski W.P., Murray T.M., Anastassiades T., Hopman W., Brown J.P., Kirkland S., Joyce C., Papaioannou A., Poliquin S., Tenenhouse A. and Papadimitropoulos E.A. (2003). The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos. Int. 14, 895-904.
2. Ajubi N.E., Klein-Nulend J., Alblas M.J., Burger E.H. and Nijweide P.J. (1999). Signal transduction pathways involved in fluid flow-induced PGE2 production by cultured osteocytes. Am. J. Physiol. 276, 171178.
3. Bergström I., Parini P., Gustafsson S.A., Andersson G. and Brinck J. (2012). Physical training increases osteoprotegerin in postmenopausal women. J. Bone. Miner. Metab. 30, 202-207.
4. Bijlsma J.W., Saag K.G., Buttgereit F. and da Silva J.A. (2005). Developments in glucocorticoid therapy. Rheum. Dis. Clin. North. Am. 31, 1-17.
5. Boyle W.J., Simonet W.S. and Lacey D.L. (2003). Osteoclast differentiation and activation. Nature 423, 337-342.
6. Burge R., Dawson-Hughes B., Solomon D.H., Wong J.B., King A. and Tosteson A. (2007). Inci dence and economi c burden of osteoporosis-related fractures in the United States, 2005-2025. J. Bone Miner. Res. 22, 465-475.
7. Canalis E., Bilezikian J.P., Angeli A. and Giustina A. (2004). Perspectives on glucocorticoid-induced osteoporosis. Bone 34, 593-598.
8. Cardile V., Musumeci G., Sicurezza E., Caggia S., Rusu M.C., Leonardi R. and Loreto C. (2013). TRAIL and its receptors DR5 and DcR2 expression, in Orthodontic Tooth Movement. Histol. Histopathol. 28, 933-940.
9. Cardinale M. and Bosco C. (2003). The use of vibration as an exercise intervention. Exerc. Sport. Sci. Rev. 31, 3-7.
10. Cardinale M. and Rittweger J. (2006). Vibration exercise makes your muscles and bones stronger: fact or fiction? J. Br. Menopause. Soc. 12, 12-18.
11. Catenacci V.A. and Wyatt H.R. (2007). The role of physical activity in producing and maintaining weight loss. Nat. Clin. Pract. Endocrinol. Metab. 3, 518-529.
12. Delmas P.D. (2008). Clinical potential RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone disease. J. Clin. Densitom. 11, 325-338.
13. Eghbali-Fatourechi G., Khosla S., Sanyal A., Boyle W.J., Lacey D.L. and Riggs B.L. (2003). Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J. Clin. Invest. 111, 1221-1230.
14. Flieger J., Karachalios T., Khaldi L., Raptou P. and Lyritis G. (1998). Mechanical stimulati on in the form of vibration prevents postmenopausal bone loss in ovariectomized rats. Calcif. Tissue. Int. 63, 510-514.
15. Folwarczna J., Pytlik M., Sliwinski L., Cegiela U., Nowinska B. and Rajda M. (2011). Effects of propranolol on the development of glucocorticoid-induced osteoporosis in male rats. Pharmacol. Rep. 63, 1040-1049.
16. Fritton J.C., Rubin C.T., Qin Y.X. and McLeod K.J. (1997). Whole-body vibration in the skeleton: development of a resonance-based testing device. Ann. Biomed. Eng. 25, 831-839.
17. Gold D.T. (2001). The nonskeletal consequences of osteoporotic fractures. Psychologic and social outcomes. Rheum. Dis. Clin. North. Am. 27, 255-262.
18. Hofbauer L.C. and Heufelder A.E. (2001). The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis. Arthritis. Rheum. 44, 253-259.
19. Huang L., Xu J., Wood D.J., Zheng M.H. (2000). Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation. Am. J. Pathol. 156, 761-767.
20. Iwamoto J., Takeda T., Sato Y. and Uzawa M. (2005). Effect of wholebody vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate. Aging Clin. Exp. Res. 17, 157-163.
21. Kenny A.M., Smith J., Noteroglu E., Waynik I.Y., Ellis C., Kleppinger A., Annis K., Dauser D. and Walsh S. (2009). Osteoporosis risk in frail older adults in assisted living. J. Am. Geriatr. Soc. 57, 76-81.
22. Lane N.E. (2001). An update on glucocorticoid-induced osteoporosis. Rheum. Dis. Clin. North. Am. 27, 235-253.
23. Lau E., Al-Dujaili S., Guenther A., Liu D., Wang L. and You L. (2010). Effect of low-magnitude, high-frequency vibration on osteocytes in the regulation of osteoclasts. Bone 46, 1508-1515.
24. Lips P. and van Schoor N.M. (2005). Quality of life in patients with osteoporosis. Osteoporos. Int. 16, 447-455.
25. Liu D., Xu J.K., Figliomeni L., Huang L., Pavlos N.J., Rogers M., Tan A., Price P. and Zheng M.H. (2003). Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. Int. J. Mol. Med. 11, 17-21.
26. Loreto C., Musumeci G., Castorina A., Loreto C. and Martines G. (2011a). Degenerative disc disease of herniated intervertebral discs is associated with extracellular matrix remodelling, vimentin-positive cells and cell death. Ann. Anat. 193, 156-162.
27. Loreto C. Barbagli G. Djinovic R. Vespasiani G. Carnazza M.L. Miano R. Musumeci G. Sansalone S. (2011b). Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Its death receptor (DR5) in Peyronie's disease. A Biomolecular Study of Apoptosis Activation. J. Sex. Med. 8, 109-115.
28. Loreto C., Lo Castro E., Musumeci G., Loreto F., Rapisarda G., Rezzani R., Castorina S., Leonardi R. and Rusu M.C. (2012). Aquaporin 1 expression in human temporomandibular disc. Acta. Histochem. 114, 744-748.
29. Maddalozzo G.F., Iwaniec U.T., Turner R.T., Rosen C.J. and Widrick J.J. (2008). Whole-body vibration slows the acquisition of fat in mature female rats. Int. J. Obes. (Lond). 32, 1348-1354.
30. Manolagas S.C. and Weinstein R.S. (1999). New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J. Bone. Miner. Res. 14, 1061-1066.
31. Marques E.A., Wanderley F., Machado L., Sousa F., Viana J.L., Moreira-Gonçalves D., Moreira P., Mota J. and Carvalho J. (2011). Effects of resistance and aerobic exercise on physical function, bone mineral density, OPG and RANKL in older women. Exp. Gerontol. 46, 524-32.
32. Musumeci G., Loreto C., Carnazza M.L. and Martinez G. (2011a). Characterization of apoptosis in articular cartilage derived from the knee joints of patients with osteoarthritis. Knee Surg. Sports Traumatol. Arthrosc. 19, 307-313.
33. Musumeci G., Loreto C., Carnazza M.L., Coppolino F., Cardile V. and Leonardi R. (2011b). Lubricin is expressed in chondrocytes derived from osteoarthritic cartilage encapsulated in poly (ethylene glycol) diacrylate scaffold. Eur. J. Histochem. 55, e31.
34. Musumeci G., Loreto C., Carnazza M.L., Strehin I. and Elisseeff J. (2011c). OA cartilage derived chondrocytes encapsulated in poly(ethylene glycol) diacrylate (PEGDA) for the evaluation of cartilage restoration and apoptosis in an in vitro model. Histol. Histopathol. 26, 1265-1278.
35. Musumeci G., Lo Furno D., Loreto C., Giuffrida R., Caggia S., Leonardi R. and Cardile V. (2011d). Mesenchymal stem cells from adipose tissue which have been differentiated into chondrocytes in three dimensional culture express lubricin. Exp. Biol. Med. 236, 1333 1341.
36. Musumeci G., Loreto C., Clementi G., Fiore C.E. and Martinez G. (2011e). An in vivo experimental study on osteopenia in diabetic rats. Acta. Histochem. 113, 619-625.
37. Musumeci G., Carnazza M.L., Leonardi R. and Loreto C. (2012a). Expression of ß-Defensin-4 in "an in vivo and ex vivo model" of human osteoarthritic knee meniscus. Knee Surg. Sports Traumatol. Arthrosc. 20, 216-222.
38. Musumeci G., Carnazza M.L., Loreto C., Leonardi R. and Loreto C. (2012b). ß-Defensin-4 (HBD-4) is expressed in chondrocytes derived from normal and osteoarthritic cartilage encapsulated in PEGDA scaffold. Acta. Histochem. 14, 805-812.
39. Musumeci G., Leonardi R., Carnazza M.L., Cardile V., Pichler, K., Weinberg, A.M. and Loreto C. (2013). Aquaporin 1 (AQP1) expression in experimentally induced osteoarthritic knee menisci: An in vivo and in vitro study. Tissue Cell 45, 145-152.
40. Musumeci G., Loreto C., Carnazza M.L., Cardile V. and Leonardi R. (2012d). Acute injury affects lubricin expression in knee menisci: An immunohistochemical study. Ann. Anat. 195, 151-158.
41. Rittweger J., Ehrig J., Just K., Mutschelknauss M., Kirsch K.A. and Felsenberg D. (2002). Oxygen uptake in whole-body vibration exercise: influence of vibration frequency, amplitude, and external load. Int. J. Sports. Med. 23, 428-432.
42. Rizzoli R., Bruyere O., Cannata-Andia J.B., Devogelaer J.P., Lyritis G., Ringe J.D., Vellas B. and Reginster J.Y. (2009). Management of osteoporosis in the elderly. Curr. Med. Res. Opin. 25, 2373-2387.
43. Rodella L.F., Favero G., Boninsegna R., Borgonovo A., Rezzani R. and Santoro F. (2010). TGF-beta1 and VEGF after fresh frozen bone allograft insertion in oral-maxillo-facial surgery. Histol. Histopathol. 25, 463-471.
44. Roelants M., Delecluse C. and Verschueren S.M. (2004). Whole-bodyvibration training increases knee-extension strength and speed of movement in older women. J. Am. Geriatr. Soc. 52, 901-908.
45. Rubin C., Turner A.S., Bain S., Mallinckrodt C. and McLeod K. (2001a). Anabolism, Low mechanical signals strengthen long bones. Nature. 412, 603-604.
46. Rubin C., Xu G. and Judex S. (2001b). The anabolic activity of bone tissue, suppressed by disuse, is normalized by brief exposure to extremely low-magnitude mechanical stimuli. FASEB J. 15, 2225-2229.
47. Rubin C., Turner A.S., Muller R., Mittra E., McLeod K., Lin W. and Qin X.Y. (2002). Quantity and quality of trabecular bone in the femur are enhanced by a strongly anabolic, noninvasive mechanical intervention. J. Bone Miner. Res. 17, 349-357.
48. Rubin C., Pope M., Fritton J.C., Magnusson M., Hansson T. and McLeod K. (2003). Transmissibility of 15-hertz to 35-hertz vibrations to the human hip and lumbar spine: determining the physiologic feasibility of delivering low-level anabolic mechanical stimuli to skeletal regions at greatest risk of fracture because of osteoporosis. Spine 28, 2621-2627.
49. Rubin C., Recker R., Cullen D., Ryaby J., McCabe J. and McLeod K. (2004). Prevention of postmenopausal bone loss by a lowmagnitude, high-frequency mechanical stimuli: a clinical trial assessing compliance, efficacy, and safety. J. Bone Miner. Res. 19, 343-351.
50. Schacke H., Docke W.D. and Asadullah K. (2002). Mechanisms involved in the side effects of glucocorticoids. Pharmacol. Ther. 96, 23-43.
51. Semler O., Fricke O., Vezyroglou K., Stark C., Stabrey A. and Schoenau E. (2008). Results of a prospective pilot trial on mobility after whole body vibration in children and adolescents with osteogenesis imperfecta. Clin. Rehabil. 22, 387-394.
52. Torvinen S., Sievanen H., Jarvinen T.A., Pasanen M., Kontulainen S. and Kannus P. (2002). Effect of 4-min vertical whole body vibration on muscle performance and body balance: a randomized cross-over study. Int. J. Sports Med. 23, 374-379.
53. Tosteson A.N and Hammond C.S. (2002). Quality-of-life assessment in osteoporosis: health-status and preference-based measures. Pharmacoeconomics 20, 289-303.
54. Verschueren S.M., Roelants M., Delecluse C., Swinnen S., Vanderschueren D. and Boonen S. (2004). Effect of 6-month whole body vibration training on hip density, muscle strength, and postural control in postmenopausal women: a randomized controlled pilot study. J. Bone Miner. Res. 19, 352-359.
55. Weinstein R.S., Jia D., Powers C.C., Stewart S.A., Jilka R.L., Parfitt A.M and Manolaqas S.C. (2004). The skeletal effects of glucocorticoid excess override those of orchidectomy in mice. Endocrinology 145, 1980-1987.
56. You L., Temiyasathit S., Lee P., Kim C.H., Tummala P., Yao W., Kingery W., Malone A.M., Kwon R.Y. and Jacobs C.R. (2008). Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading. Bone 42, 172-179.